跳至主要内容
临床试验/ACTRN12617000783325
ACTRN12617000783325已完成2 期

Restoration Of gut miCroflora in CrITical Illness (The ROCIT trial): A multicentre Randomised controlled trial of probiotic therapy to reduce nosocomial infection and increase days alive and out of hospital in critically ill patients admitted to the intensive care unit.

Fiona Stanley Hospital0 个研究点目标入组 220 人开始时间: 2017年5月29日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • * Admitted to the ICU or high dependency area for less than 48 hours
  • * Anticipated to require intensive care or high dependency area care beyond the next calendar day

排除标准

  • 1. less than 18 years of age
  • 2. Absolute contraindication to receiving medication via the enteral route
  • 3. Known to be receiving probiotic therapy at time of index hospitalisation
  • 4. Acute pancreatitis as a cause or complication of current admission
  • 5. Immunosuppressed, e.g. chemotherapy within four weeks of admission, receiving greater than or equal to 1.5mg/kg methylprednisolone daily or equivalent for more than four days
  • 6. Neutropenia (neutrophil count less than 1x109/L)
  • 7. Prosthetic heart valve or permanent pace maker
  • 8. Death is deemed to be inevitable as a result of the current acute illness AND either the treating clinician, the patient, or the substitute decision maker are not committed to full active treatment
  • 9. Enrolment not considered in the patient’s best interest
  • 10. Previously enrolled in the ROCIT study
  • 11. Unlikely to be residing in the Perth Metropolitan area in 60 days time
  • 12. Participating in a competing interventional study
  • 13. Pregnancy
  • 14. Admitted to hospital from a high level nursing facility or rehabilitation facility

研究者

相似试验